Stieg D, Casey K, Karisetty B, Leu J, Larkin F, Vogel P
Mol Cell Biol. 2024; 44(12):607-621.
PMID: 39520074
PMC: 11583612.
DOI: 10.1080/10985549.2024.2421885.
Patrick N, Markey M
Int J Mol Sci. 2024; 25(17).
PMID: 39273363
PMC: 11395681.
DOI: 10.3390/ijms25179415.
Ntwasa M
Cells. 2024; 13(13.
PMID: 38994976
PMC: 11240505.
DOI: 10.3390/cells13131124.
Wang W, Albadari N, Du Y, Fowler J, Sang H, Xian W
Pharmacol Rev. 2024; 76(3):414-453.
PMID: 38697854
PMC: 11068841.
DOI: 10.1124/pharmrev.123.001026.
Chandramohan A, Josien H, Yuen T, Duggal R, Spiegelberg D, Yan L
Nat Commun. 2024; 15(1):489.
PMID: 38216578
PMC: 10786919.
DOI: 10.1038/s41467-023-43346-4.
P53 together with ferroptosis: a promising strategy leaving cancer cells without escape.
Zhan J, Wang J, Liang Y, Zeng X, Li E, Wang H
Acta Biochim Biophys Sin (Shanghai). 2023; 56(1):1-14.
PMID: 38105650
PMC: 10875350.
DOI: 10.3724/abbs.2023270.
Recent Advances in Transcription Factors Biomarkers and Targeted Therapies Focusing on Epithelial-Mesenchymal Transition.
Chuang K, Chiou S, Hsu S
Cancers (Basel). 2023; 15(13).
PMID: 37444447
PMC: 10340346.
DOI: 10.3390/cancers15133338.
DNA-Encoded Macrocyclic Peptide Libraries Enable the Discovery of a Neutral MDM2-p53 Inhibitor.
Silvestri A, Zhang Q, Ping Y, Muir E, Zhao J, Chakka S
ACS Med Chem Lett. 2023; 14(6):820-826.
PMID: 37312849
PMC: 10258823.
DOI: 10.1021/acsmedchemlett.3c00117.
Targeting USP2 regulation of VPRBP-mediated degradation of p53 and PD-L1 for cancer therapy.
Yi J, Tavana O, Li H, Wang D, Baer R, Gu W
Nat Commun. 2023; 14(1):1941.
PMID: 37024504
PMC: 10079682.
DOI: 10.1038/s41467-023-37617-3.
Therapeutic Strategies to Activate p53.
Aguilar A, Wang S
Pharmaceuticals (Basel). 2023; 16(1).
PMID: 36678521
PMC: 9866379.
DOI: 10.3390/ph16010024.
Dual Targeting of MDM4 and FTH1 by MMRi71 for Induced Protein Degradation and p53-Independent Apoptosis in Leukemia Cells.
Lama R, Galster S, Xu C, Davison L, Chemler S, Wang X
Molecules. 2022; 27(22).
PMID: 36431769
PMC: 9695299.
DOI: 10.3390/molecules27227665.
The role of ubiquitination in spinal and bulbar muscular atrophy.
Sengupta M, Pluciennik A, Merry D
Front Mol Neurosci. 2022; 15:1020143.
PMID: 36277484
PMC: 9583669.
DOI: 10.3389/fnmol.2022.1020143.
MDMX Regulates Transcriptional Activity of p53 and FOXO Proteins to Stimulate Proliferation of Melanoma Cells.
Heijkants R, Teunisse A, de Jong D, Glinkina K, Mei H, Kielbasa S
Cancers (Basel). 2022; 14(18).
PMID: 36139642
PMC: 9496676.
DOI: 10.3390/cancers14184482.
The Therapeutic Potential of the Restoration of the p53 Protein Family Members in the -Mutated Lung Cancer.
Fregni M, Ciribilli Y, Zawacka-Pankau J
Int J Mol Sci. 2022; 23(13).
PMID: 35806218
PMC: 9267050.
DOI: 10.3390/ijms23137213.
Novel Allosteric Mechanism of Dual p53/MDM2 and p53/MDM4 Inhibition by a Small Molecule.
Grinkevich V, Vema A, Fawkner K, Issaeva N, Andreotti V, Dickinson E
Front Mol Biosci. 2022; 9:823195.
PMID: 35720128
PMC: 9198586.
DOI: 10.3389/fmolb.2022.823195.
SNPs in miRNAs and Target Sequences: Role in Cancer and Diabetes.
Chhichholiya Y, Suryan A, Suman P, Munshi A, Singh S
Front Genet. 2021; 12:793523.
PMID: 34925466
PMC: 8673831.
DOI: 10.3389/fgene.2021.793523.
Screening for the Key Proteins Associated with Rete Testis Invasion in Clinical Stage I Seminoma via Label-Free Quantitative Mass Spectrometry.
Borszekova Pulzova L, Roska J, Kalman M, Kliment J, Slavik P, Smolkova B
Cancers (Basel). 2021; 13(21).
PMID: 34771736
PMC: 8583098.
DOI: 10.3390/cancers13215573.
Systemic therapies for salivary gland adenoid cystic carcinoma.
Sahara S, Herzog A, Nor J
Am J Cancer Res. 2021; 11(9):4092-4110.
PMID: 34659878
PMC: 8493384.
Targeting mutant p53 for cancer therapy: direct and indirect strategies.
Hu J, Cao J, Topatana W, Juengpanich S, Li S, Zhang B
J Hematol Oncol. 2021; 14(1):157.
PMID: 34583722
PMC: 8480024.
DOI: 10.1186/s13045-021-01169-0.
MDM2/X Inhibitors as Radiosensitizers for Glioblastoma Targeted Therapy.
Miles X, Vandevoorde C, Hunter A, Bolcaen J
Front Oncol. 2021; 11:703442.
PMID: 34307171
PMC: 8296304.
DOI: 10.3389/fonc.2021.703442.
